skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

About Laura

USA

+30 year(s) experience

Laura Runkel |Pharma Intelligence|
Associate Director Laura Runkel supports clinical trial intelligence for the autoimmune/inflammation, CNS and ophthalmology therapeutic areas. She tracks drug development and related clinical trials to prepare analytical reports and provide clients with direct insights.

Analyst Articles

Articles by Laura

  • Clinical trial intelligence

    Pharmaprojects

    Novel Biologics for Asthma: Steps on the Long Road to Therapies for Uncontrolled Asthma

    By Laura Runkel 28 Nov 2016

    After many years of research, the first two novel biologics have been filed for approval for uncontrolled, eosinophilic asthma treatment. Will the hope for truly targeted therapies for uncontrolled asthma now be realized? After many years of research, the first two novel biologics have been filed for approval for uncontrolled, eosinophilic asthma treatment. Will the hope for truly targeted therapies for uncontrolled asthma now be realized?

;

Tweets from Laura